Seeking Alpha
View as an RSS Feed

David Zanoni  

View David Zanoni's Comments BY TICKER:
Latest  |  Highest rated
  • Aflac: Never Ducking On Dividends [View article]
    Yes, Japan does pose a risk for Aflac - but every business has its risks. The high exposure to Japan is probably contributing to Aflac's undervaluation. You have to go with your gut and decide for yourself if you are willing to own that risk or invest in something with less risk. Of course, the stocks with less risk may not be undervalued.
    Feb 10, 2013. 05:01 PM | 2 Likes Like |Link to Comment
  • The Herbalife Controversy: A Historical Perspective [View article]
    Mr. Fitzpatrick,

    I appreciate your article. I was wondering if you have the time what you thought about this MLM company: http://bit.ly/WGohdx
    Feb 2, 2013. 09:28 PM | Likes Like |Link to Comment
  • How McDonald's Is Addressing Competitive Challenges In 2013 [View article]
    On my most recent trip to McDonald's, I had the Southwest Grilled Chicken Salad and enjoyed it. I think I'll go with the healthier choices more often.
    Jan 27, 2013. 03:20 PM | 2 Likes Like |Link to Comment
  • In Defense Of Apple: Battling The Mounting Hysteria [View article]
    Investors should be looking for a company that pays a decent dividend, with billions in cash, zero debt, an undervaluation compared to the overall market, and above average growth. Oh wait, that company IS Apple. Look at where the company is and where it is going. Sure, there are some uncertainties, but every company faces the unknown. Sure, the company may not grow as exponentially as the past decade, but it will grow at an above average pace. I can't say where the bottom will be in the stock, but it should do well for the long-term.
    Jan 24, 2013. 07:51 PM | 15 Likes Like |Link to Comment
  • A Look At Warren Buffett's Energy Stocks [View article]
    MidAmerican is a utility owned by Berkshire.
    Jan 23, 2013. 06:59 PM | Likes Like |Link to Comment
  • NuPathe Gets FDA Approval: What's Next For The Stock [View article]
    stocknerd,

    It was not inferred that users would take 2 pills of sumatriptan at once, but 2 pills per month, assuming 2 episodes per month. (1 pill per episode).
    Jan 22, 2013. 07:34 PM | Likes Like |Link to Comment
  • NuPathe Gets FDA Approval: What's Next For The Stock [View article]
    mel1360,

    I simply used the current outstanding shares of 14.75 million.
    Jan 21, 2013. 03:37 PM | Likes Like |Link to Comment
  • NuPathe Gets FDA Approval: What's Next For The Stock [View article]
    jhenn,

    Although the company stated that it is seeking a partnership, I guess a buyout is not totally out of the question. A buyout could be offered for a nice premium - it all depends on what the acquiring company is willing to pay. If Zecuity does have blockbuster potential (sales of over $1 billion), then the stock could be taken out at a nice premium, perhaps at $7 or more. A price of $7 would allow a company to acquire NuPathe for $103.25 million for the potential of adding over $1 billion in annual revenue.
    Jan 21, 2013. 09:49 AM | 1 Like Like |Link to Comment
  • NuPathe Gets FDA Approval: What's Next For The Stock [View article]
    joe,

    That is usually the case when the stock pops much higher upon the news of the approval. However, the stock didn't rise much on the news - it is trading below where it was just a few months ago.
    Jan 21, 2013. 09:38 AM | Likes Like |Link to Comment
  • Upcoming FDA Approval Decision Dates For Q1 2013 [View article]
    Allctt,

    Here's the link you requested: http://bit.ly/Uuro6j
    Jan 16, 2013. 08:13 PM | Likes Like |Link to Comment
  • Upcoming FDA Approval Decision Dates For Q1 2013 [View article]
    Ashraf,

    It's good to see a fellow contributor enjoying the article.
    Jan 14, 2013. 07:44 PM | Likes Like |Link to Comment
  • Upcoming FDA Approval Decision Dates For Q1 2013 [View article]
    Yes, Ponatinib was given early approval in Dec. - sorry about that - my source did not have it marked as approved early and they usually are on top of that. Nevertheless, I should have doubled checked. I'll have Ariad eliminated.
    Jan 14, 2013. 05:27 AM | Likes Like |Link to Comment
  • How Apple Gets To $400 A Share [View article]
    Apple's stock is just waiting for the next catalyst. The company reports earnings on Jan. 23 - the stock will move again based on earnings for the quarter and how the company guides for future quarters. The past earnings report was a disappointment and the company guided lower. This had a lot to do with the direction of the stock for the past few months. Things can turn around quickly with a new positive report - we'll just have to see.
    Jan 13, 2013. 09:54 AM | 7 Likes Like |Link to Comment
  • McDonald's Continued Success Is Largely About Infrastructure [View article]
    Mark,

    Well said - I have to agree. The company has a knack for giving consumers what they crave in specific markets throughout the world. The menu can be changed as tastes and trends change.
    Jan 12, 2013. 12:51 PM | Likes Like |Link to Comment
  • Consumer Staples ETF Is Beating The Market [View article]
    varan,

    You're right FDFAX did edge higher than XLP over that time period in terms of price appreciation. However, keep in mind that FDFAX has a lower yield of 1.43% and a higher expense ratio of 0.82%. Personally, I think the higher yield and lower expense ratio makes XLP more attractive.
    Jan 12, 2013. 11:34 AM | Likes Like |Link to Comment
COMMENTS STATS
1,104 Comments
1,074 Likes